These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 26433527

  • 1. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
    Fujimura T, Kawamoto S.
    Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
    [Abstract] [Full Text] [Related]

  • 2. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [Abstract] [Full Text] [Related]

  • 3. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M.
    Int Arch Allergy Immunol; 2015 Oct; 168(1):32-43. PubMed ID: 26524293
    [Abstract] [Full Text] [Related]

  • 4. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K, Okamoto N, Saito A, Yasueda H, Takase Y, Shimakura H, Saito S, Sakaguchi M.
    Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996
    [Abstract] [Full Text] [Related]

  • 5. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F.
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [Abstract] [Full Text] [Related]

  • 6. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 7. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
    Osada T, Okano M.
    Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
    [Abstract] [Full Text] [Related]

  • 8. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.
    Ogihara K, Savory N, Abe K, Yoshida W, Arakawa M, Asahi M, Kamohara S, Ikebukuro K.
    Nucleic Acid Ther; 2015 Dec; 25(6):311-6. PubMed ID: 26484654
    [Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen.
    Fujimura T, Futamura N, Midoro-Horiuti T, Togawa A, Goldblum RM, Yasueda H, Saito A, Shinohara K, Masuda K, Kurata K, Sakaguchi M.
    Allergy; 2007 May; 62(5):547-53. PubMed ID: 17441795
    [Abstract] [Full Text] [Related]

  • 11. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
    Sakaida H, Masuda S, Takeuchi K.
    Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114
    [Abstract] [Full Text] [Related]

  • 12. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis.
    Nagao M, Hiraguchi Y, Hosoki K, Tokuda R, Usui T, Masuda S, Yamaguchi M, Fujisawa T.
    Int Arch Allergy Immunol; 2008 Sep; 146 Suppl 1():47-53. PubMed ID: 18504407
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
    Saito S, Takagi H, Wakasa Y, Ozawa K, Takaiwa F.
    Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161
    [Abstract] [Full Text] [Related]

  • 14. Molecular cloning and characterization of a new Japanese cedar pollen allergen homologous to plant isoflavone reductase family.
    Kawamoto S, Fujimura T, Nishida M, Tanaka T, Aki T, Masubuchi M, Hayashi T, Suzuki O, Shigeta S, Ono K.
    Clin Exp Allergy; 2002 Jul; 32(7):1064-70. PubMed ID: 12100055
    [Abstract] [Full Text] [Related]

  • 15. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y, Yokomoto Y, Ohashi-Doi K.
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [Abstract] [Full Text] [Related]

  • 16. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
    Inuo C, Ando H, Tanaka K, Nakajima Y, Tsuge I, Urisu A, Kondo Y.
    Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
    [No Abstract] [Full Text] [Related]

  • 17. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609
    [Abstract] [Full Text] [Related]

  • 18. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Clin Exp Allergy; 2005 May 18; 35(5):664-71. PubMed ID: 15898991
    [Abstract] [Full Text] [Related]

  • 19. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K.
    J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255
    [Abstract] [Full Text] [Related]

  • 20. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun 01; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.